PERCEPTIVE ADVISORS LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001224962

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2024 · 98 positions · Total reported value $3.53B · Top-10 concentration 51.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.5% · 26 new · 28 cut · 12 exited

Active Share (vs S&P 500): 98.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +23.3% · vs SPY +8.4% · Prev Value $4.76B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2024 13F filing, PERCEPTIVE ADVISORS LLC disclosed 98 equity positions with a combined reported value of $3.53B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 51.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were VRNA ($296.85M), ACLX ($266.80M), FOLD ($228.40M). By sector, the heaviest allocations are Health Care 55.8%, Industrials 0.9%. Versus the prior quarter, allocation shifted toward Other (+2.9pp) and away from Health Care (-2.8pp).

Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 26 new positions, trimmed 28 and fully exited 12, a turnover rate of 55.5% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q4 2024 were JANX ($43.79M), IKT ($19.26M), PEN ($17.42M).

Of the 12 positions fully exited versus the prior quarter, the largest were BHVN ($74.22M), XBI ($39.52M), TIL ($23.26M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • JANX JANUX THERAPEUTICS INC · $43.79M
  • IKT INHIBIKASE THERAPEUTICS INC · $19.26M
  • PEN PENUMBRA INC · $17.42M
  • SEPN SEPTERNA INC · $17.18M
  • DRUG BRIGHT MINDS BIOSCIENCES INC · $14.54M
  • AVR ANTERIS TECHNOLOGIES GLOBAL COM · $11.94M
  • EW EDWARDS LIFESCIENCES CORP · $10.73M
  • RAPT RAPT THERAPEUTICS INC · $9.29M

Fully Exited (vs previous quarter)

  • BHVN BIOHAVEN LTD · prev qtr: $74.22M
  • XBI SPDR SERIES TRUST · prev qtr: $39.52M · history
  • TIL INSTIL BIO INC · prev qtr: $23.26M
  • LIVN LIVANOVA PLC · prev qtr: $22.54M
  • SWTX SPRINGWORKS THERAPEUTICS INC · prev qtr: $22.18M
  • MDT MEDTRONIC PLC · prev qtr: $22.09M
  • IRON DISC MEDICINE INC · prev qtr: $19.02M
  • ICLR ICON PUB LTD CO · prev qtr: $12.74M

Insider Transactions (Form 4)

Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-26 Opt exercise LeonaBio, Inc. 776,648 $0.00 SEC filing
2026-08-26 Buy Immatics N.V. 863,060 $8.69 SEC filing
2026-07-20 Award Freenome, Inc. 5,500,000 $10.00 SEC filing
2026-06-17 Award Kardigan, Inc. 20,706 — SEC filing
2026-04-17 Award MeiraGTx Holdings plc 555,555 $9.00 SEC filing

All insider transactions →

Fund Profile

Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 107 US equity positions with a combined value of $6.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-71841 (status: Approved), registered 2010-10-04
  • Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 17 private funds, of which 6 hedge funds

Portfolio Structure

  • 107 positions · $6.30B reported value (Q2 2026)
  • Top 10 holdings = 47.5% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 10.8%
  • Average position size: $58.91M

Sector Tilt

  • Health Care 89.0%
  • Industrials 1.2%
  • Financials 0.1%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 26 new, 28 added, 28 reduced, 12 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 55.8%
Other 43.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.39M $296.85M 8.42%
8.42%
Add
2 3.48M $266.80M 7.57%
7.57%
Reduce
3 24.25M $228.40M 6.48%
6.48%
Reduce
4 3.68M $206.03M 5.84%
5.84%
Add
5 2.62M $205.09M 5.82%
5.82%
Reduce
6 22.11M $163.63M 4.64%
4.64%
Reduce
7 1.72M $140.67M 3.99%
3.99%
Reduce
8 1.29M $107.60M 3.05%
3.05%
Reduce
9 6.35M $106.35M 3.02%
3.02%
Add
10 2.79M $79.87M 2.27%
2.27%
Hold
11 12.58M $76.58M 2.17%
2.17%
Hold
12 2.69M $71.70M 2.03%
2.03%
Add
13 1.50M $67.47M 1.91%
1.91%
Reduce
14 9.38M $66.72M 1.89%
1.89%
Add
15 232.27K $60.64M 1.72%
1.72%
Add
16 2.57M $59.94M 1.70%
1.70%
Reduce
17 6.49M $57.98M 1.64%
1.64%
Hold
18 5.15M $56.81M 1.61%
1.61%
Reduce
19 664.07K $56.19M 1.59%
1.59%
Reduce
20 3.68M $53.11M 1.51%
1.51%
Hold
21 2.14M $52.99M 1.50%
1.50%
Reduce
22 1.27M $49.09M 1.39%
1.39%
Reduce
23 1.05M $47.44M 1.34%
1.34%
Reduce
24 9.28M $46.29M 1.31%
1.31%
Hold
25 817.89K $43.79M 1.24%
1.24%
New
26 67.47K $41.49M 1.18%
1.18%
Reduce
27 995.89K $40.07M 1.14%
1.14%
Reduce
28 500.00K $38.48M 1.09%
1.09%
Reduce
29 1.19M $32.98M 0.94%
0.94%
Reduce
30 63.12K $32.95M 0.93%
0.93%
Add
31 5.36M $32.27M 0.92%
0.92%
Hold
32 2.13M $31.18M 0.88%
0.88%
Reduce
33 2.36M $30.92M 0.88%
0.88%
Hold
34 1.49M $28.50M 0.81%
0.81%
Reduce
35 6.91M $27.63M 0.78%
0.78%
Hold
36 6.77M $25.61M 0.73%
0.73%
Add
37 290.66K $23.40M 0.66%
0.66%
Reduce
38 12.59M $21.16M 0.60%
0.60%
Hold
39 1.44M $21.11M 0.60%
0.60%
Reduce
40 125.00K $19.79M 0.56%
0.56%
Reduce
41 5.92M $19.26M 0.55%
0.55%
New
42 4.59M $18.37M 0.52%
0.52%
Hold
43 73.34K $17.42M 0.49%
0.49%
New
44 750.00K $17.18M 0.49%
0.49%
New
45 845.57K $16.40M 0.47%
0.47%
Reduce
46 1.06M $16.39M 0.47%
0.47%
Hold
47 890.28K $15.27M 0.43%
0.43%
Reduce
48 403.65K $14.54M 0.41%
0.41%
New
49 740.75K $14.20M 0.40%
0.40%
Reduce
50 100.05K $13.66M 0.39%
0.39%
Reduce

FAQ

What did PERCEPTIVE ADVISORS LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, PERCEPTIVE ADVISORS LLC reported 98 equity positions worth $3.53B in aggregate; its largest disclosed positions were VRNA ($296.85M), ACLX ($266.80M), FOLD ($228.40M).

How large is PERCEPTIVE ADVISORS LLC's portfolio?

PERCEPTIVE ADVISORS LLC reported $3.53B of long equity holdings across 98 positions as of 2024-Q4. Top-10 holdings account for 51.1% of reported value.

What is PERCEPTIVE ADVISORS LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/perceptive-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →